The concept of metrological traceability of measurement results to property values assigned to measurement standards of higher metrological order or to the International System of Units (SI) through sequential calibrations, using reference materials and reference measurement procedures, plays a key role in ensuring that end user measurement procedures perform at an acceptable level in the clinical context. The aim is that measurement results produced over time or by different end users or with different end user measurement procedures for the same measurand will be equivalent within their corresponding uncertainties. These goals can only be reached under certain conditions and if requirements laid down in international standards on calibration concepts, reference measurement procedures and reference materials are fulfilled. Calibration hierarchies have to be implemented correctly and parameters contributing to measurement uncertainty and systematic bias need to be controlled and eliminated, respectively, by technically improving methods and reference materials and intermediate calibrators used for effectively achieving equivalence of measurement results and for meeting analytical performance requirements for in vitro diagnostic devices.
Introduction
In order to contribute to the reliability and unambiguity of clinical decision-making a sufficiently high level of quality in terms of precision, reproducibility and clinical performance of data produced by clinical laboratories is needed. The increasing mobility of people, the use and exchange of data originating from different laboratories for research and public healthcare purposes besides patient follow-up and the resulting demand for uniform reference ranges, decision limits and equivalent measurement results are putting even higher quality requirements on results of laboratory medicine. The global dimension of the diagnostics industry and cross-border trading call also for measures to guarantee an adequate level of performance of diagnostic devices.
These goals can be achieved by efficiently implemented standardisation based on the concept of metrological traceability. Consequently, the fundamental concept of traceability has been introduced in legislation, such as the EU Directive on In Vitro Diagnostic Medical Devices (IVD-MD) (Directive 98/79/EC), which requires traceability of values assigned to calibrators and control materials to reference measurement procedures (RMPs) and/or reference materials (RMs) of higher order [1] . The ISO 17511 [2] and ISO 18153 [3] standards issued by the International Organization for Standardization (ISO) describe how standardisation based on the traceability concept can be established for in vitro diagnostics. This concept is also embedded in standards on requirements and competences of laboratories, such as ISO/IEC 17025 [4] , ISO 15195 [5] and ISO 15189 [6] . RMs and RMPs play a key role in establishing a calibration hierarchy or in the reverse sequence a traceability chain for measurement data of in vitro diagnostics and hence in achieving the performance goals of end user methods applied in laboratory medicine. However, in order to define performance targets for RMs and RMPs their intended use and role in calibration hierarchies has to be considered. Sources of bias and imprecision, not only at the highest levels of the calibration hierarchy but down to the level of the end user measurement procedure (i.e., the in vitro diagnostic device as applied by the end users in medical laboratories) need to be understood. RMPs have to be designed and RMs to be characterised appropriately to serve effectively the overall goal of achieving equivalence of measurement results within analytical performance goals set by clinical needs. Consequently, traceability should not be considered as a purpose on its own. It is far from being a pure formalism and should be correctly implemented to become effective in terms of equivalence and reproducibility of measurement results.
General requirements for establishing an efficient calibration hierarchy
A calibration hierarchy is built and traceability of measurement results to higher order measurement standards is achieved by an unbroken sequence of calibrations for which bias should be eliminated. According to the law of error propagation each calibration step is introducing additional uncertainty contributions on top of the uncertainty of values assigned to RMs and intermediate calibrators at the previous (i.e., higher) calibration hierarchy level. Hence the uncertainty of values assigned to calibrators and finally end user results is always increasing through a traceability chain. The combination of the uncertainty contributions is explained in the Guide to the expression of uncertainty of measurement (GUM) [7] . As described in ISO 17511:2003 [2] , traceability of measurement results can be achieved via measurement standards, of which values are traceable to the international system of units (SI) or are defined by the reference measurement procedure applied, or to conventional measurement standards such as those provided by the World Health Organisation (WHO). As the arbitrary units of the latter are defined by the particular material constituting the standard the arbitrary scale is more prone to lacking reproducibility.
ISO 17511:2003 [2] lays down requirements for establishing a traceability chain. The measurand needs to be defined adequately and needs to be maintained throughout the traceability chain. It should be noted that ISO 17511:2003 [2] refers to the former definition of the measurand given in the second edition of the International Vocabulary of Basic and General Terms in Metrology (VIM2) [8] which is 'the particular quantity subject to measurement' and is composed of the analyte, a unit and the system or in other words the matrix. Bias shall be eliminated at any stage and the use of commutable RMs and intermediate calibrators [9] makes an important contribution to this elimination. Otherwise the traceability chain would be broken and no equivalence of measurement results within their corresponding uncertainties could be expected. Since both, RMs of higher metrological order and intermediate calibrators are used for calibration in the traceability chain they are referred to as calibrators in the remaining discussion. The property values of the afore mentioned RMs of higher metrological order are typically certified and the intermediate calibrators, such as manufacturer's working calibrator or kit calibrator, have to be considered as a kind of RM.
However, in practice the measurand according to the VIM2 definition is not maintained throughout the traceability chain and is frequently defined by the measurement procedures applied. Typical calibration hierarchies look more like in Figure 1 . The measurands (VIM2 definition) of the purity assessment, gravimetric preparation of calibration solutions and of different measurement procedures involved in the calibration hierarchy are not the same. An example for different measurands (VIM2 definition) of measurement procedures would be the quantification of a protein by analysis of selected peptides after tryptic digest vs. immunoassay(s) detecting certain epitopes. In a calibration hierarchy the measurement procedures based on different principles and targeting the molecule or mixtures of molecules of interest would intend to measure the same quantity. The latter complies with the definition of the measurand according to ISO/IEC Guide 99:2007 (also called VIM3) [10] . However, the change of the definition of the measurand from VIM2 to VIM3 has significant conceptual implications on ISO 17511:2003 and its potential revision.
In practical terms results obtained by different measurement procedures involved in a calibration hierarchy must correlate closely for calibrators and clinical samples [11] . For achieving measurement result equivalence for individual clinical samples and between different end user measurement procedures for the same measurand (VIM3 definition) close correlation of results for the higher order RM used for their calibration and clinical samples is a fundamental requirement. Commutability of both, RMs and intermediate calibrators is required to minimise systematic bias between measurement procedures calibrated with them [2, 9] . The relative residual for the property value of the calibrator compared to the regression line for typical clinical samples using two measurement procedures for which the commutability of the calibrator needs to be assessed, corresponds to the systematic bias between the two measurement procedures for clinical samples if no correction would take place. Bias correction would be related to an uncertainty contribution.
Thus the correlation between results of measurement procedures as well as the commutability of calibrators are key issues for the successful standardisation and the fulfilment of stringent analytical performance goals. The design of a commutability study and the criteria applied for assessing the commutability and suitability of RMs as calibrators need to be consistent with the analytical performance goals for end user results of end user measurement procedures as defined by clinical needs. The International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) has established a working group which is currently looking into criteria for commutability assessment taking existing guidance, such as EP30-A [9] , into consideration. In Figure 2 an example of a commutability assessment is given based on real data for the clinical samples [12]. Two fictive RMs at low and high concentration would fulfil the widely used acceptance criterion (also proposed in EP-30-A [9] ) of falling into the 95% prediction interval of a Deming regression. If such RMs would be used for the calibration of the two end user measurement procedures of interest the resulting systematic bias would be considerable, and may be well beyond analytical performance requirements. The bias would also depend on the concentration and depending on the location of the decision or reference interval limits may have different implications. Hence acceptance criteria for commutability should be rather derived from the possibly concentration dependent analytical performance requirements for the methods for which the calibrator would be used for. Although commutability of the calibrators is mandatory for achieving equivalence of measurement results, it does not guarantee the absence of bias. Elimination of bias may require the identification and control of all relevant influence parameters and quantities and eventually multiparametric traceability. For example, determining only the amount of substance of a protein fragment may not be sufficient to control measurements well enough. Also the isoform pattern, the presence of artefacts, the interaction with other compounds or structural information may have to be taken into consideration. Common calibration protocols using commutable RMs and commutable dilutions thereof need to be developed, if necessary.
As addressed earlier the correlation of data from end user measurement procedures for clinical samples determines the degree of equivalence of values for individual clinical samples which can be achieved for the two measurement procedures. A lack of correlation caused by differences in selectivity of end user measurement procedures would produce biased results on individual samples. This bias cannot be removed by calibration with even perfectly characterised and commutable RMs and corresponds to the relative residuals for individual clinical samples which are basically unpredictable. If the bias on such samples would be too large to meet analytical performance goals, preference should be given to the end user measurement procedure with better clinical performance. Then at least one method would have to be redesigned regarding its selectivity to ensure equivalence of measurement results.
A lacking correlation between results of measurement procedures used in a calibration hierarchy, including RMPs, is likely to introduce uncontrolled bias and could make calibrators non-commutable. For instance, it could be shown for human growth hormone (hGH) that despite the good correlation between data from end user measurement procedures (all immunoassays) neither the international standard for hGH (WHO 98/574) nor dilutions of the standard were commutable which led to a breach in the traceability chain and explained the persistent discrepancies between results from end user measurement procedures [13] . It was also shown that a mass spectrometry based candidate RMP targeting peptides originating from digested hGH did not correlate well on clinical samples with the end user measurement procedures. Further investigations on peptides from tryptic digest confirmed the lacking correlation of this candidate RMP and end user measurement procedures [14] . The relative residuals of the correlation plots could reach 30% and more depending on the individual sample and the concentration range. To apply a RMP with such a low correlation in the calibration hierarchy is of limited utility for standardisation. Commutable RMs may be obtained by pooling a larger number of individual sample donations. However, the selection of individual samples and the way how they are pooled may introduce arbitrariness. The reproducibility of the properties of the pools would have to be verified. The RMP could not be applied to individual clinical or other types of samples without running into the risk of introducing bias and consequently limitations in drawing conclusions.
In summary the analyte of the RMP has be known and the calibrators have to be well characterised for setting up a calibration hierarchy leading to equivalent measurement results. The analyte needs to be identical for RMPs and end user measurement procedures or a sufficiently close correlation for results on calibrators and clinical samples has been established.
General requirements for reference measurement procedures and reference materials
General requirements for RMPs are described in ISO 15193:2009 [15] . Amongst others they comprise a description of the measurement principle and method, definition of the measurand or analyte, specification of reagents and other materials as well as equipment and apparatus used, identification of the influence quantities, description of the preparation of the measurement system and analytical portion, a calibration protocol and data on analytical reliability (sensitivity, linearity, recovery, uncertainty, repeatability, reproducibility, limit of detection) and validation. The uncertainty of the measurement results must be sufficiently low for accurately assigning values to calibrators.
The development of RMs is a complex process in which various aspects need to be considered. It requires thorough [18] describes the general and statistical principles for certification. The certified property value should be obtained using adequate and highest quality (reference) measurement procedures and a traceability statement for the certified value has to be provided. A commutability statement in line with the intended use shall be given as well. A RM must be thoroughly characterised in terms of homogeneity and stability. Both characteristics should be assessed for the intended measurement conditions in a way that absence of relevant heterogeneity and instability is demonstrated within the measurement uncertainty rather than the inability to detect any heterogeneity or instability. Homogeneity and stability studies are associated to uncertainties which predominantly depend on the precision of the measurement procedure applied (it could hide possibly remaining heterogeneity or instability). Table 1 provides an example of the components of the relative combined standard uncertainty of the certified value for the mass concentration of cystatin C in human serum for ERM-DA471 [19] . The uncertainty of the certified value has to be significantly lower than the analytical performance goals for end user measurement procedures because it is part of the error propagation in a calibration hierarchy.
Reduction of uncertainties to meet analytical performance requirements
When establishing a calibration hierarchy consideration has to be given to the performance requirements for the end user measurement procedure and the different uncertainty contributions introduced by the end user and the calibration process carried out by the IVD manufacturer [20, 21] . In the calibration process uncertainties are introduced by the measurement procedures used in a calibration hierarchy, including RMPs, as well as the uncertainties of property values of calibrators and RMs. Consequently for meeting analytical performance requirements of end user measurement procedures adequate calibration protocols, measurement procedures, RMs and intermediate calibrators have to be used.
It is a considerable challenge to reduce uncertainties of certified property values of a RM or uncertainties associated with a RMP for meeting analytical performance requirements of end user measurement procedures. At present it may often be not technically possible or very resource demanding.
However, underestimation and omission of relevant uncertainty components or neglecting influence parameters or quantities in the calibration hierarchy would lead to a lack of bias control and elimination as well as to measurement results which would not be equivalent within their stated uncertainties. Underestimation of uncertainties is therefore not a valid route for complying with stringent analytical performance goals. Uncertainty estimates based on expert judgement and internal or external quality assurance data (type B uncertainties [7] ) should be realistic and reductions of uncertainties should be real, i.e., achieved by technical improvements. A sound assessment of uncertainties is demanding and requires technical insight and experience. Examples for occasional underestimations of measurement uncertainties, even by laboratories applying RMPs, can be found on the RELA and BIPM webpages (e.g., results of the proficiency test for reference measurement services for progesterone in 2013 [22] or for the key comparison K6 amongst national metrology institutes on cholesterol [23] ). A reduction of uncertainties and elimination of bias in a calibration hierarchy require the further technical development on calibrators and measurement procedures as well as adaptations of end user measurement procedures. Since each calibration step is adding to the overall measurement uncertainty a reduction of the number of calibration steps might be an option. The extended use of both RMPs and well characterised RMs also at lower levels of the calibration hierarchy may reduce uncertainties. In the ideal case the end user measurement procedure could be directly calibrated by the manufacturer of the in vitro diagnostic device with a commutable RM of higher metrological order which would reduce accumulation of uncertainties to a minimal extent.
Conclusions
Determining performance criteria for RMPs and RMs requires a holistic approach taking their characteristics and role in calibration hierarchies into consideration. RMs and RMPs cannot stand alone, but they are integral parts of reference measurement systems. The application of RMs outside their validated intended use requires additional verification of their usability. A lacking correlation of results among end user measurement procedures limits the capacity to meet analytical performance goals because of the persistent bias for data on individual clinical samples. The close interrelations of measurement procedures and calibrators used in a calibration hierarchy for clinical samples, and the related commutability of those calibrators play an important role in meeting analytical performance targets. The specifications and characteristics of RMPs and RMs may be such that justified performance targets of end user measurement procedures cannot be met. In this case the omission or underestimation of measurement uncertainties is not a valid solution. Instead, a better understanding, control and elimination of sources of bias and imprecision, a more stringent and clinically more relevant definition of the quantity subject to measurement, a reduction of the number of calibration steps carried out in a calibration hierarchy and technical improvements of calibrator properties, measurement procedure performance as well as of the end user measurement procedures would ensure the equivalence of measurement results over space and time and a true improvement in meeting analytical performance goals.
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